GB1552099A - Cephalosporin analogues - Google Patents

Cephalosporin analogues

Info

Publication number
GB1552099A
GB1552099A GB32111/77A GB3211177A GB1552099A GB 1552099 A GB1552099 A GB 1552099A GB 32111/77 A GB32111/77 A GB 32111/77A GB 3211177 A GB3211177 A GB 3211177A GB 1552099 A GB1552099 A GB 1552099A
Authority
GB
United Kingdom
Prior art keywords
hydrogen
cephalosporin analogues
cephalosporin
analogues
thioheterocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB32111/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of GB1552099A publication Critical patent/GB1552099A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB32111/77A 1976-08-05 1977-08-01 Cephalosporin analogues Expired GB1552099A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51093809A JPS609514B2 (ja) 1976-08-05 1976-08-05 7−アミノ−3′−ノルセファロスポラン酸類

Publications (1)

Publication Number Publication Date
GB1552099A true GB1552099A (en) 1979-09-05

Family

ID=14092721

Family Applications (1)

Application Number Title Priority Date Filing Date
GB32111/77A Expired GB1552099A (en) 1976-08-05 1977-08-01 Cephalosporin analogues

Country Status (10)

Country Link
JP (1) JPS609514B2 (de)
BE (1) BE857482A (de)
CA (1) CA1090336A (de)
CH (1) CH637135A5 (de)
DE (1) DE2735408A1 (de)
FR (1) FR2360594A1 (de)
GB (1) GB1552099A (de)
IE (1) IE45459B1 (de)
IL (1) IL52668A (de)
NL (1) NL7708722A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197402A (en) * 1976-08-09 1980-04-08 Shionogi & Co., Ltd. Cephalosporin analogues
AU514377B2 (en) * 1977-02-15 1981-02-05 Shionogi & Co., Ltd. l-OXADETHIACEPHAM COMPOUNDS
IT1102408B (it) * 1977-12-23 1985-10-07 Fujisawa Pharmaceutical Co Composti analoghi della cefalosforina e procedimenti per la loro preparazione
CA1262128A (en) * 1981-08-27 1989-10-03 Christian N. Hubschwerlen .beta.-lactams
JPS5910591A (ja) * 1982-07-09 1984-01-20 Meiji Seika Kaisha Ltd 1−オキサデチアセフアロスポリン化合物及びそれを含む抗菌剤
HRP970146A2 (en) * 1997-03-13 1998-10-31 Mice Kovacevic Epoxi-azetidines, preparation and use

Also Published As

Publication number Publication date
NL7708722A (nl) 1978-02-07
JPS609514B2 (ja) 1985-03-11
JPS5318597A (en) 1978-02-20
CH637135A5 (en) 1983-07-15
CA1090336A (en) 1980-11-25
FR2360594A1 (fr) 1978-03-03
IL52668A0 (en) 1977-10-31
BE857482A (fr) 1978-02-06
DE2735408A1 (de) 1978-02-09
IE45459L (en) 1978-02-05
IL52668A (en) 1981-03-31
FR2360594B1 (de) 1980-02-08
IE45459B1 (en) 1982-08-25

Similar Documents

Publication Publication Date Title
SE8004792L (sv) Nya tetra- eller pentapeptider, forfaranden for framstellning av desamma och farmaceutiska kompositioner innehallande desamma
JPS5513278A (en) Benzomorphane compound and medical compound containing it
SE8604950L (sv) Demensforbettrande och terapeutiska medel
SE7813274L (sv) Peptidderivat och forfarande for framstellning derav
GB1552099A (en) Cephalosporin analogues
SE7605361L (sv) Sett att framstella nya n-substituerade fenylpiperazinderivat
ES543301A0 (es) Cefalosporinas
FI832582A (fi) Foerfarande foer framstaellning av nya tieno-tiazol-derivat och dessa foereningar innehaollande laekemedel
GB1503280A (en) Aminoalkanesulphonic acid derivative
FI870811A (fi) Pentapeptider med en cellvaextreglerande effekt och ett foerfarande foer framstaellning av desamma.
DE69212267D1 (de) Echinocandin-B-Derivat
GB2019843A (en) N-Alkenylmoranoline derivatives
FI840743A0 (fi) N-(3-trifluormetylfenyl)-n'-propargylpiperazin, dess framstaellning och anvaendning
GB2017103A (en) Cephalosporin analogues
SE8401280D0 (sv) Mellanprodukter och forfaraden for framstellning derav
IL71987A0 (en) Nortropine derivative and its preparation
SE7707418L (sv) Nya svavelhaltiga n-bensylaminosyror och forfarande for framstellning derav
FI924769A (fi) Foerfarande foer framstaellning av substituerade indoler
SE7714526L (sv) Sett att framstella 2-amino-cyklopent-1-en-1-tiokarbonyl-disulfider
GB2001068A (en) Penicillin and cephalosporin preparation
ES8201567A1 (es) Procedimiento para la obtencion de un agente anti-infarto miocardio

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee